Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Revolution Medicines (RVMDW) Competitors

Revolution Medicines logo
$5.40 +0.30 (+5.88%)
Closing price 03:57 PM Eastern
Extended Trading
$5.25 -0.15 (-2.76%)
As of 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

RVMDW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Revolution Medicines stock or one of its competitors? MarketBeat compares Revolution Medicines with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Revolution Medicines include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Revolution Medicines compare to 60 Degrees Pharmaceuticals?

Revolution Medicines (NASDAQ:RVMDW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation.

In the previous week, Revolution Medicines' average media sentiment score of 0.00 equaled 60 Degrees Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Revolution Medicines Neutral
60 Degrees Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.01MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

60 Degrees Pharmaceuticals beats Revolution Medicines on 1 of the 1 factors compared between the two stocks.

How does Revolution Medicines compare to Alpha Tau Medical?

Revolution Medicines (NASDAQ:RVMDW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, media sentiment, risk and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Alpha Tau Medical had 1 more articles in the media than Revolution Medicines. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Revolution Medicines. Revolution Medicines' average media sentiment score of 0.00 equaled Alpha Tau Medical'saverage media sentiment score.

Company Overall Sentiment
Revolution Medicines Neutral
Alpha Tau Medical Neutral

Summary

Alpha Tau Medical beats Revolution Medicines on 1 of the 1 factors compared between the two stocks.

How does Revolution Medicines compare to Apollomics?

Apollomics (NASDAQ:APLMW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, media sentiment, analyst recommendations, earnings, valuation and risk.

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
Revolution Medicines N/A N/A N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled Revolution Medicines'average media sentiment score.

Company Overall Sentiment
Apollomics Neutral
Revolution Medicines Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

Summary

Apollomics beats Revolution Medicines on 1 of the 1 factors compared between the two stocks.

How does Revolution Medicines compare to BioVie?

BioVie (NASDAQ:BIVIW) and Revolution Medicines (NASDAQ:RVMDW) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, risk, institutional ownership, profitability and analyst recommendations.

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Revolution Medicines N/A N/A N/A

In the previous week, BioVie's average media sentiment score of 0.00 equaled Revolution Medicines'average media sentiment score.

Company Overall Sentiment
BioVie Neutral
Revolution Medicines Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Revolution MedicinesN/AN/AN/AN/AN/A

Summary

BioVie and Revolution Medicines tied by winning 0 of the 0 factors compared between the two stocks.

How does Revolution Medicines compare to Cardio Diagnostics?

Revolution Medicines (NASDAQ:RVMDW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, valuation, risk, profitability, media sentiment, analyst recommendations, earnings and institutional ownership.

In the previous week, Revolution Medicines' average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company Overall Sentiment
Revolution Medicines Neutral
Cardio Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
Revolution MedicinesN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revolution MedicinesN/AN/AN/AN/AN/A
Cardio Diagnostics$14.83KN/AN/AN/AN/A

Summary

Cardio Diagnostics beats Revolution Medicines on 1 of the 1 factors compared between the two stocks.

Get Revolution Medicines News Delivered to You Automatically

Sign up to receive the latest news and ratings for RVMDW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RVMDW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

RVMDW vs. The Competition

Export
MetricRevolution MedicinesBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$465.73M$6.25B$12.23B
Dividend YieldN/A3.87%2.80%5.27%
P/E RatioN/A3.7620.7925.04
Price / SalesN/A7,435.94531.2172.18
Price / CashN/A13.1343.0954.25
Price / BookN/A83.539.816.83
Net IncomeN/A-$96.07M$3.55B$335.69M
7 Day Performance5.88%0.52%-2.07%-2.03%
1 Month Performance-0.55%0.18%-3.90%-1.90%
1 Year Performance2,638.34%71.17%29.39%27.36%

Revolution Medicines Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
RVMDW
Revolution Medicines
N/A$5.40
+5.9%		N/A+2,450.0%$0.00N/AN/A378
SXTPW
60 Degrees Pharmaceuticals
N/A$0.05
+16.0%		N/AN/A$0.00$1.01MN/A2
DRTSW
Alpha Tau Medical
N/A$1.76
-11.6%		N/A+891.2%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
-0.6%		N/A+47.0%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.29
+1.1%		N/AN/A$0.00N/AN/AN/A

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:RVMDW) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel